Atlas Trials

Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry

Clinical trial NCT06569095 · RECRUITING

Trial details

NCT number
NCT06569095
Sponsor
Peking University People's Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Myelodysplastic Syndromes
Start date
2024-12-09
Primary completion
2027-12-17
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.